A role for endogenous mono-hydroxy-eicosatetraenoic acids (HETEs) in the regulation of human neutrophil migration.

Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 0374672 Publication Model: Print Cited Medium: Print ISSN: 0019-2805 (Print) Linking ISSN: 00192805 NLM ISO Abbreviation: Immunology Subsets: MEDLINE

Original Publication: Oxford : Blackwell Scientific Publications

Arachidonic Acids/*physiology ; Neutrophils/*physiology; 5,8,11,14-Eicosatetraynoic Acid/pharmacology ; Arachidonic Acids/blood ; Catechols/pharmacology ; Cell Movement/drug effects ; Chemotaxis, Leukocyte/drug effects ; Humans ; Lipoxygenase Inhibitors ; Masoprocol ; Neutrophils/analysis ; Oxidation-Reduction ; Subcellular Fractions/analysis

The possibility that endogenous monohydroxy-eicosatetraenoic acids (HETEs) derived from the lipoxygenation of arachidonic acid might serve a role in human neutrophil migration was examined by studying the effects of depletion of the intracellular HETEs on random migration and chemotaxis. The intracellular contents of approximately 2000 ng of 11-HETE and 500 ng of 5-HETE per 10(8) neutrophils are distributed preferentially in the cellular membranes and are increased by specific chemotactic factors. The depletion of intracellular HETEs that resulted from pre-incubating, washing and resuspending neutrophils in 3-20 microM 5,8,11,14-eicosatetraynoic acid (TYA), an inhibitor of lipoxygenase and cyclooxygenase activity, or in 5-10 microM nordihydroguaiaretic acid (NDGA), a selective inhibitor of lipoxygenase activity, was associated with suppression of neutrophil random migration and chemotaxis to several stimuli without evidence of cytotoxicity. Maximal suppression of migration was achieved by a 30-60 min preincubation with the inhibitors, a time-course analogous to that required for optimal depletion of the endogenous HETEs. In contrast, inhibitors of cyclooxygenase activity enhanced random migration and, to a lesser extent, chemotaxis. The inhibition of migration achieved by pre-incubating and maintaining the neutrophils in TYA or NDGA was fully reversed either by washing and resuspending the neutrophils in buffer or by the addition of purified neutrophil 5-HETE in quantities as small as 20 ng/2 x 10(6) neutrophils for random migration and 0.8 ng/2 x 10(6) neutrophils for chemotaxis, while the addition of 11-HETE was less effective. The relationship of the intracellular concentrations of endogenous HETEs to neutrophil migration is consistent with a potential role of the HETEs as cellular mediators.

Infect Immun. 1971 Aug;4(2):97-102. (PMID: 5154881)
J Immunol. 1980 Feb;124(2):926-33. (PMID: 7356719)
Prep Biochem. 1978;8(2-3):147-53. (PMID: 714876)
J Clin Invest. 1977 Jan;59(1):179-83. (PMID: 830662)
Annu Rev Biochem. 1975;44:669-95. (PMID: 806254)
J Biol Chem. 1976 Dec 25;251(24):7816-20. (PMID: 826538)
Arch Biochem Biophys. 1953 Feb;42(2):293-304. (PMID: 13031632)
Biochim Biophys Acta. 1973 Feb 14;296(2):374-81. (PMID: 4734624)
Proc Natl Acad Sci U S A. 1974 Sep;71(9):3400-4. (PMID: 4215079)
J Exp Med. 1971 Oct 1;134(4):907-34. (PMID: 4106490)
Immunology. 1980 Feb;39(2):141-9. (PMID: 7380464)
J Exp Med. 1979 Aug 1;150(2):406-11. (PMID: 458381)
J Bacteriol. 1949 Dec;58(6):731-6. (PMID: 15395173)
J Cell Biol. 1973 Feb;56(2):275-303. (PMID: 4264788)
Biochem Biophys Res Commun. 1974 Dec 11;61(3):942-9. (PMID: 4451568)
J Clin Invest. 1974 Mar;53(3):726-34. (PMID: 4812436)
J Exp Med. 1972 Dec 1;136(6):1564-80. (PMID: 4641855)
J Lipid Res. 1967 Jul;8(4):321-7. (PMID: 5231291)
Biochim Biophys Acta. 1975 Feb 20;380(2):299-307. (PMID: 804329)
Nature. 1975 Oct 23;257(5528):680-1. (PMID: 810723)
J Cell Biol. 1974 Oct;63(1):251-69. (PMID: 4371042)
J Exp Med. 1975 Jun 1;141(6):1437-41. (PMID: 1127383)
Scand J Clin Lab Invest Suppl. 1968;97:31-50. (PMID: 4179066)
Immunology. 1979 Jun;37(2):407-18. (PMID: 89083)
Infect Immun. 1977 Feb;15(2):436-43. (PMID: 14892)
J Immunol. 1978 Feb;120(2):526-31. (PMID: 621391)

0 (Arachidonic Acids)
0 (Catechols)
0 (Lipoxygenase Inhibitors)
1191-85-1 (5,8,11,14-Eicosatetraynoic Acid)
7BO8G1BYQU (Masoprocol)

Date Created: 19800801 Date Completed: 19810116 Latest Revision: 20181113

20250114

PMC1458102

6776039